SCHEMBL30120767

SCHEMBL30120767

Cc1cccc(-n2ncc3c(O)nc(CCl)nc32)c1

nearest known ligand 0.52

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
GRM1 Q13255 2/20 0.52
NPC1 O15118 7/20 0.48
RAB9A P51151 7/20 0.48
KDM4E B2RXH2 7/20 0.48
HSD17B10 Q99714 4/20 0.48
HTT P42858 3/20 0.48
NPSR1 Q6W5P4 2/20 0.48
BLM P54132 1/20 0.48
SMN1; SMN2 Q16637 7/20 0.47
LMNA P02545 7/20 0.47
TP53 P04637 6/20 0.47
ALDH1A1 P00352 5/20 0.47
TSHR P16473 2/20 0.47
HPGD P15428 3/20 0.45
THRB P10828 1/20 0.45
MAPT P10636 7/20 0.44
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23723551 1.00 GRM1 (0.52) GRM1NPC1RAB9AKDM4EHSD17B10
SCHEMBL30120729 0.86 SMN1; SMN2 (0.50) NPC1RAB9AKDM4EHSD17B10HTT
SCHEMBL23723574 0.86 SMN1; SMN2 (0.50) NPC1RAB9AKDM4EHSD17B10HTT
SCHEMBL23723527 0.85 SMN1; SMN2 (0.51) GRM1NPC1RAB9AHTTNPSR1
SCHEMBL23723660 0.84 KMT2A (0.47) GRM1NPC1RAB9AKDM4EHSD17B10
SCHEMBL23723532 0.78 GRM5 (0.49) GRM1NPC1RAB9AHTTNPSR1
SCHEMBL23723775 0.77 SMN1; SMN2 (0.51) NPC1RAB9AKDM4EHSD17B10HTT
SCHEMBL30132105 0.75 GRM1 (0.42) GRM1NPC1RAB9AKDM4EHSD17B10
SCHEMBL23723600 0.72 SLC2A1 (0.45) NPC1RAB9AKDM4ELMNATP53
SCHEMBL30120627 0.72 SLC2A1 (0.45) NPC1RAB9AKDM4ELMNATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4100015-A1 COMBINATION THERAPY FOR TREATING MPS1 Gain Therapeutics SA (CH) 2022-12-14 EP disclosed
CN-115397423-A Combination therapy for the treatment of MPS1 增益治疗股份有限公司 2022-11-25 CN disclosed